Montana bill would require standardized cannabis warning labels; health groups back it, industry objects to graphic posters

Representative Melody Cunningham opened testimony on House Bill 792 at the Senate Business, Labor and Economic Affairs Committee, saying the bill "is to ensure that consumers have access to clear, visible, and effective health warnings at the point of cannabis sale." She told senators she reviewed Cannabis Control Division rules and dispensary packaging and found inconsistent and often unreadable warnings; HB 792 would add standardized point-of-sale posters, require a caution triangle icon, set a minimum legible font size for exit envelopes and replace the clinical term "cannabinoid hyperemesis" with the plain-language phrase "excessive vomiting." Cunningham also said the bill would require a warning that driving under the influence of marijuana is a crime.

Public-health and clinical witnesses urged passage. Liana Troesh of Safe Montana said the change was a "common sense solution," arguing images plus text better communicate risks to children and people who cannot read. Lauren Wilson, a pediatrician and immediate past president of the Montana chapter of the American Academy of Pediatrics, told the committee she has seen pregnant and breastfeeding patients use cannabis and cautioned about developmental and adolescent mental‑health risks. Colleen Smith (Youth Connections) and Jean Branscum (Montana Medical Association) cited studies and traffic-safety data and provided draft posters with helpline contacts such as 2-1-1 and SAMHSA resources.

Industry witnesses pushed back, especially over so-called "graphic depictions" the bill would allow. Pepper Peterson of the Montana Cannabis Guild said HB 792 "creates a precedent" and called proposed images "vile," arguing they would harm customers and staff and could spark litigation; he asked the committee to table the bill. Kate Holeeva of the Montana Cannabis Industry Association urged regulatory parity with alcohol and tobacco and asked for a longer implementation window for label orders. Producer witnesses (Antoinette Leininger of Sacred Sun Farms and Evan Kajander representing industry retailers) disputed some of the public‑health claims cited by proponents and objected to being excluded from decisions about any imagery used.

Kristen Barber, administrator of the Cannabis Control Division, appeared as an informational witness and told the committee that current enforcement typically starts with education and escalates to civil penalties; packaging compliance issues historically have been handled by guidance and civil penalties, with suspension or revocation available but rarely used. Barber explained Montana’s adoption of an ASTM marijuana symbol and said the department would work with stakeholders in rulemaking if the legislature passes statutory language that leaves details to regulation. On the question of helplines, Barber confirmed resources exist but said the division has not previously been required to require those resources on packaging.

Committee members focused questions on poster design, legal risk, where materials would appear (exit envelopes versus individual product labels), the proposed plain‑language change from "cannabinoid hyperemesis" to "excessive vomiting," and whether state cannabis tax revenue should fund treatment or prevention. Representative Cunningham said she considered the graphic images a potential “Pandora’s box” and expressed a willingness to accept amendments and stakeholder input.

The committee closed the hearing after extended Q&A; no final vote was taken in the transcript.

The transcript evidence: sponsor presentation; proponents from medical and prevention groups; industry opponents and trade associations; informational testimony from the Cannabis Control Division. The committee raised implementation timing, rulemaking and legal‑risk questions that the sponsor and administrative witness said could be addressed through amendments and the rulemaking process.